Novo Nordisk A/SNVONYSE
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+158.3%
5Y CAGR+67.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+158.3%/yr
vs +45.2%/yr prior
5Y CAGR
+67.1%/yr
Recent acceleration
Acceleration
+113.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
13x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.52B | +297.4% |
| 2024 | $1.64B | +202.6% |
| 2023 | $542.00M | +43.4% |
| 2022 | $378.00M | +30.8% |
| 2021 | $289.00M | -42.3% |
| 2020 | $500.84M | +1.3% |
| 2019 | $494.47M | +481.7% |
| 2018 | $85.00M | -5.6% |
| 2017 | $90.00M | +38.5% |
| 2016 | $65.00M | - |